دورية أكاديمية

Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitor.

التفاصيل البيبلوغرافية
العنوان: Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitor.
المؤلفون: Nishimura Y; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Francis JN; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112.; Navigen, Inc., Salt Lake City, UT 84108., Donau OK; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Jesteadt E; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Sadjadpour R; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Smith AR; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215., Welch BD; Navigen, Inc., Salt Lake City, UT 84108., Martin MA; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892; malm@nih.gov kay@biochem.utah.edu., Kay MS; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112; malm@nih.gov kay@biochem.utah.edu.
المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Sep 08; Vol. 117 (36), pp. 22436-22442. Date of Electronic Publication: 2020 Aug 20.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Washington, DC : National Academy of Sciences
مواضيع طبية MeSH: Anti-HIV Agents*/chemistry , Anti-HIV Agents*/pharmacology , Anti-HIV Agents*/therapeutic use , HIV*/drug effects , HIV*/genetics , HIV Infections*/drug therapy , HIV Infections*/prevention & control , HIV Infections*/virology , Simian Immunodeficiency Virus*/drug effects , Simian Immunodeficiency Virus*/genetics, Virus Internalization/*drug effects, Animals ; Drug Evaluation, Preclinical ; Female ; HIV Envelope Protein gp41/antagonists & inhibitors ; Macaca mulatta ; Male
مستخلص: Cholesterol-PIE12-trimer (CPT31) is a potent d-peptide HIV entry inhibitor that targets the highly conserved gp41 N-peptide pocket region. CPT31 exhibited strong inhibitory breadth against diverse panels of primary virus isolates. In a simian-HIV chimeric virus AD8 (SHIVAD8) macaque model, CPT31 prevented infection from a single high-dose rectal challenge. In chronically infected animals, CPT31 monotherapy rapidly reduced viral load by ∼2 logs before rebound occurred due to the emergence of drug resistance. In chronically infected animals with viremia initially controlled by combination antiretroviral therapy (cART), CPT31 monotherapy prevented viral rebound after discontinuation of cART. These data establish CPT31 as a promising candidate for HIV prevention and treatment.
Competing Interests: The authors declare no competing interest.
(Copyright © 2020 the Author(s). Published by PNAS.)
التعليقات: Erratum in: Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):24003. (PMID: 32929023)
References: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13813-8. (PMID: 12370415)
N Engl J Med. 2020 Mar 19;382(12):1124-1135. (PMID: 32130806)
N Engl J Med. 2020 Mar 19;382(12):1112-1123. (PMID: 32130809)
Retrovirology. 2019 Oct 22;16(1):28. (PMID: 31640718)
Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19769-74. (PMID: 23129652)
J Virol. 2010 Nov;84(21):11235-44. (PMID: 20719956)
J Virol. 2000 Aug;74(15):6935-45. (PMID: 10888632)
Infect Genet Evol. 2015 Dec;36:210-216. (PMID: 26371064)
Top HIV Med. 2010 Dec;18(5):156-63. (PMID: 21245516)
J Exp Med. 2014 Sep 22;211(10):2061-74. (PMID: 25155019)
J Virol. 2010 May;84(9):4769-81. (PMID: 20147396)
AIDS. 2002 May 3;16(7):1051-8. (PMID: 11953472)
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15613-7. (PMID: 9861018)
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16828-33. (PMID: 17942675)
N Engl J Med. 2018 Aug 16;379(7):645-654. (PMID: 30110589)
N Engl J Med. 1998 Mar 26;338(13):853-60. (PMID: 9516219)
J Virol. 2005 May;79(10):6089-101. (PMID: 15857994)
N Engl J Med. 2016 Sep 1;375(9):830-9. (PMID: 27424812)
Nature. 2017 Mar 23;543(7646):559-563. (PMID: 28289286)
Mol Pharm. 2018 Mar 5;15(3):1169-1179. (PMID: 29436835)
Lancet HIV. 2020 Mar;7(3):e164-e172. (PMID: 31911147)
J Virol. 2010 Feb;84(3):1439-52. (PMID: 19939925)
Bioconjug Chem. 2012 Jun 20;23(6):1252-8. (PMID: 22545664)
J Virol. 2012 Aug;86(16):8516-26. (PMID: 22647691)
Lancet. 2002 Jul 13;360(9327):119-29. (PMID: 12126821)
Nature. 2013 Nov 14;503(7475):277-80. (PMID: 24172896)
Lancet HIV. 2019 Nov;6(11):e788-e799. (PMID: 31558423)
Cell. 2016 Jun 16;165(7):1621-1631. (PMID: 27315479)
J Virol. 1988 Jan;62(1):139-47. (PMID: 3257102)
J Virol. 2002 Mar;76(5):2123-30. (PMID: 11836389)
معلومات مُعتمدة: R56 AI076168 United States AI NIAID NIH HHS; R01 AI076168 United States AI NIAID NIH HHS; U44 AI095172 United States AI NIAID NIH HHS; R44 AI095172 United States AI NIAID NIH HHS; SB1 AI095172 United States AI NIAID NIH HHS; P50 AI150464 United States AI NIAID NIH HHS; R43 AI095172 United States AI NIAID NIH HHS
فهرسة مساهمة: Keywords: HIV entry inhibitor; HIV prevention; HIV treatment; NHP HIV model; d-peptide
المشرفين على المادة: 0 (Anti-HIV Agents)
0 (HIV Envelope Protein gp41)
تواريخ الأحداث: Date Created: 20200822 Date Completed: 20201030 Latest Revision: 20240214
رمز التحديث: 20240214
مُعرف محوري في PubMed: PMC7486783
DOI: 10.1073/pnas.2009700117
PMID: 32820072
قاعدة البيانات: MEDLINE